Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modelling COPD in mice.

R Vlahos1, S Bozinovski, R C Gualano

  • 1Department of Medicine, Cooperative Research Center for Chronic Inflammatory Diseases, The University of Melbourne, Royal Melbourne Hospital, Parkville, Vic. 3050, Australia. rossv@unimelb.edu.au

Pulmonary Pharmacology & Therapeutics
|November 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD11b immunophenotyping identifies inflammatory profiles in the mouse and human lungs.

Mucosal immunology·2015
Same author

Search for new phenomena in final states with an energetic jet and large missing transverse momentum in <i>pp</i> collisions at [Formula: see text]TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same author

Identification and energy calibration of hadronically decaying tau leptons with the ATLAS experiment in <i>pp</i> collisions at [Formula: see text][Formula: see text].

The European physical journal. C, Particles and fields·2015
Same author

Search for a new resonance decaying to a <i>W</i> or <i>Z</i> boson and a Higgs boson in the [Formula: see text] final states with the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same author

Measurement of the top-quark mass in the fully hadronic decay channel from ATLAS data at [Formula: see text].

The European physical journal. C, Particles and fields·2015
Same author

Measurement of three-jet production cross-sections in [Formula: see text] collisions at 7 [Formula: see text] centre-of-mass energy using the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same journal

Brain-derived neurotrophic factor (BDNF) signaling in respiratory disease: Mechanisms, neuroimmune crosstalk, and therapeutic implications.

Pulmonary pharmacology & therapeutics·2026
Same journal

PD05, a novel neutrophil elastase inhibitor, mitigates LPS-induced acute lung injury in a preclinical model.

Pulmonary pharmacology & therapeutics·2026
Same journal

The preclinical discovery and development of depemokimab for severe eosinophilic asthma.

Pulmonary pharmacology & therapeutics·2026
Same journal

TROP2 as a promising therapeutic target in lung cancer: Current clinical trial landscape and future directions.

Pulmonary pharmacology & therapeutics·2026
Same journal

Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment.

Pulmonary pharmacology & therapeutics·2026
Same journal

Evodiamine protects against lung ischemia-reperfusion injury by attenuating SYK-associated TLR4/NLRP3 inflammasome activation and ferroptosis-related injury signatures.

Pulmonary pharmacology & therapeutics·2026
See all related articles

Cigarette smoke causes chronic obstructive pulmonary disease (COPD) through inflammation and cellular damage. Mouse models help identify cellular and molecular targets for new COPD therapies.

Area of Science:

  • Pulmonary Medicine
  • Toxicology
  • Immunology

Background:

  • Chronic obstructive pulmonary disease (COPD) involves persistent airflow limitation and inflammation.
  • Cigarette smoking is the primary cause of COPD, yet effective treatments are lacking.
  • Understanding cellular and molecular responses to smoke is crucial for developing new therapies.

Purpose of the Study:

  • To review mouse models used to study cigarette smoke exposure.
  • To define the cellular, molecular, and pathological consequences of smoke exposure.
  • To identify potential therapeutic targets for COPD.

Main Methods:

  • Review of existing literature on mouse models of COPD.
  • Analysis of cellular responses (neutrophilic inflammation, macrophage accumulation).

Related Experiment Videos

  • Examination of molecular responses (cytokine, chemokine, protease production).

    • Main Results:

    • Mouse models effectively replicate key features of COPD pathology.
    • Specific cellular and molecular pathways are activated by cigarette smoke.
    • These models provide insights into disease progression and potential interventions.

    Conclusions:

    • Mouse models are valuable tools for investigating COPD pathogenesis.
    • Identifying specific molecular targets can lead to novel therapeutic strategies.
    • Further research using these models may improve COPD treatment options.